Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes

Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes

Background/Aims: We assessed whether cognitive and functional decline in community-dwelling patients with mild Alzheimer disease (AD) dementia were associated with increased societal costs and caregiver burden and time outcomes. Methods: Cognitive decline was defined as a ≥3-point reduction in the M...

Full description

Bibliographic Details
Main Authors: Roy W. Jones, Jeremie Lebrec, Kristin Kahle-Wrobleski, Grazia Dell’Agnello, Giuseppe Bruno, Bruno Vellas, Josep M. Argimon, Richard Dodel, Josep Maria Haro, Anders Wimo, Catherine Reed
Format: Article
Language:English
Published: Karger Publishers 2017-03-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Cognition
Activities of daily living
Health care costs
Caregivers
Alzheimer disease
Disease progression
Health resources
Outcome assessment (health care)

Online Access:http://www.karger.com/Article/FullText/461577

Internet

http://www.karger.com/Article/FullText/461577

Similar Items